About Fraxa Research Foundation
FRAXA Research Foundation Inc centers its grantmaking on Fragile X syndrome, with a clear emphasis on moving research toward treatments and a cure. Its recent awards show a consistent pattern of support for biomedical teams working on Fragile X therapeutics, preclinical validation, and clinical research, including repeated funding to Yale School of Medicine and UMass Medical in Worcester. The foundation’s grant portfolio is built around investigator-driven research rather than individual support, and its active programs show a structured pathway from early-stage validation to human studies. FRAXA also prioritizes curative therapy approaches, including gene therapy, gene repair, gene reactivation, protein replacement, mRNA therapeutics, and targeted ASO treatments. Recent grants include $100,000 awards to Yale School of Medicine and UMass Medical, alongside many $50,000 grants to university and hospital-based research teams. That mix suggests a funder that backs both larger project awards and a broader bench of investigators working on Fragile X biology, translational models, and therapy development.
What Fraxa Research Foundation Funds
In Fragile X clinical research, FRAXA Research Foundation Inc supports human-subject studies with grants such as $50,000 to Children’s Hospital of Philadelphia for research. The foundation also backs translational work at academic medical centers: it gave $100,000 to University of California at Irvine for research and $50,000 to Massachusetts General Hospital for research. Curative therapy development is another visible priority, reflected in awards such as $50,000 to Cold Spring Harbor Laboratory for research. Its funded projects also include teams working on preclinical and biomarker-oriented research, as seen in grants to University of Rochester, Seattle Children’s Research Institute, and Cincinnati Children’s Hospital, each at $50,000. Across these examples, the focus stays on Fragile X-specific therapeutic development rather than broad neuroscience.
How Fraxa Research Foundation Gives
The typical grant size is tightly clustered: p25, median, and p75 are all $50,000. That points to a standardized award level for much of the foundation’s portfolio, with occasional larger grants at $81,401, $90,000, or $100,000. Recent recipients appear across multiple years, including Yale School of Medicine, UMass Medical, University of California at Irvine, Carnegie Mellon University, Emory University, Mercer University, Seattle Children’s Research Institute, Tufts University School of Medicine, and University of Illinois at Urbana-Champaign. The foundation is not an individual-giving or program-related-investment funder; it makes institutional research grants. Its active programs accept unsolicited applications, including fellowship, clinical trial, drug validation, and curative therapy grants.
